Raiffeisen Bank International’s Relay Therapeutics RLAY Stock Holding History

Raiffeisen Bank International’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58M	Sell	80,000 -110,000	-58%	-$1.6M	0.02%	349
2026 Q1	$1.78M	Sell	190,000 -60,000	-24%	-$537K	0.03%	316
2025 Q4	$2.09M	Buy	250,000 +30,000	+14%	+$214K	0.03%	252
2025 Q3	$1.14M	Buy	220,000 +40,000	+22%	+$153K	0.02%	316
2025 Q2	$587K	Hold	180,000	–	–	0.01%	359
2025 Q1	$490K	Hold	180,000	–	–	0.01%	372
2024 Q4	$752K	Buy	+180,000	New	+$980K	0.01%	301

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Raiffeisen Bank International's RLAY Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Relay Therapeutics (RLAY) stake by 58% in Q2 2026, selling an estimated $1.6M and leaving 80,000 shares worth $1.58M. The position accounts for 0.02% of the portfolio, ranked #349.

Raiffeisen Bank International first reported a position in RLAY in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.09M in Q4 2025. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

Raiffeisen Bank International held 80,000 shares of Relay Therapeutics worth $1.58M as of Q2 2026.
Raiffeisen Bank International sold 110,000 Relay Therapeutics shares in Q2 2026, an estimated $1.6M.
Relay Therapeutics made up 0.02% of Raiffeisen Bank International's portfolio in Q2 2026, its #349 holding.
Raiffeisen Bank International first reported a position in Relay Therapeutics in Q4 2024 and has held it in 7 quarters since.
Raiffeisen Bank International's Relay Therapeutics position peaked at $2.09M in Q4 2025.
258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.